J B Chemicals & Pharmaceuticals surged 14.65% to Rs 1111.60, extending gains for the fifth day.
On the BSE, the stock jumped 18.11% to hit the day's high at Rs 1145.15, which is also a record high for the counter. Over 1.77 lakh shares of the company were traded so far, which over 5 times the two-week average trading volume of 0.35 lakh shares.
It has added 41.14% in five sessions from its recent closing low of Rs 787.55 on 10 September 2020. The rally was triggered by the company's strong Q1 performance. Its consolidated net profit surged 92.4% to Rs 119.51 crore on 17.1% increase in net sales to Rs 522.29 crore in Q1 June 2020 over Q1 June 2019.
The strong results for Q1 FY21 were driven by growth in exports, API and chronic therapies in the domestic market, along with lower sales and marketing costs during lockdown. The results were announced after market hours on 14 September 2020.
J B Chemicals & Pharmaceuticals is a pharmaceutical company that manufactures & markets a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). It exports to many countries worldwide with presence in US, Europe, Australia, South Africa, other developing countries, Russia and CIS.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
